-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CYB-004 in Social Anxiety Disorder (SAD/Social Phobia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CYB-004 in Social Anxiety Disorder (SAD/Social Phobia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CYB-004 in Social Anxiety Disorder (SAD/Social Phobia)Drug Details:CYB-004 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GH-001 in Treatment Resistant Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GH-001 in Treatment Resistant Depression report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GH-001 in Treatment Resistant DepressionDrug Details:GH-001 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GH-001 in Bipolar II Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GH-001 in Bipolar II Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GH-001 in Bipolar II DisorderDrug Details:GH-001 is under development for the treatment...
-
Sector Analysis
Europe Fixed Broadband Market Trends and Opportunities, 2023 Update
Europe Fixed Broadband Market Report Overview The total fixed broadband revenue in Europe is $71.8 billion in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2028. Increasing fixed broadband penetration opens new opportunities for service bundling, with telcos offering multiplay bundles inclusive of services such as SVoD, pay-TV, and gaming. Europe Fixed Broadband Market Outlook 2023-2028 ($ Billion) Buy the Full Report for the Europe Fixed Broadband Market Forecast Download a Free Sample...
-
Sector Analysis
Portugal Sports Broadcasting Media (Television and Telecommunications) Landscape
Portugal Sports Broadcasting Media Market Report Overview The Portugal telecom and pay-TV services market size was estimated at $4.7 billion in 2022 and is expected to witness a CAGR growth of less than 1% over the forecast period, supported by steady growth in mobile data service revenue and in fixed broadband service revenue. Portugal Sports Broadcasting Media Market Outlook 2022-2027 ($ Billion) Buy the Full Report to Know More About the Portugal Sports Broadcasting Media Market Forecast, Download a Free...
-
52% off
Western Europe Telecom Operators Country Intelligence Report Bundle
Western Europe Telecom Operators Country Intelligence Report Bundle The future of Europe’s telecom industry depends on dynamic changes to business and operating models. The market is going through significant changes and the next step is to take the strategic initiative to ensure that the operators act as players in the future of the industry and not just mere observers. As a part of this bundle, you will gain access to in-depth insights available in the following reports: Austria Telecom Operators...
-
Report Bundle
55% offAmericas Sports Broadcasting Media Landscape – Report Bundle (7 Reports)
"The media landscape report lays the foundation for technology disruptions, ongoing M&A activity, and rapidly evolving consumer preferences in the Americas. It refers to the way people get news and entertainment through broadcasting media." As a part of this bundle, you will gain access to in-depth insights available in the following reports: Media Landscape Report: Canada Media Landscape Report: United States of America Media Landscape Report: Argentina Media Landscape Report: Brazil Media Landscape Report: Portugal Media Landscape Report: Chile Media...
-
Product Insights
Net Present Value Model: GH001
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model GH001 Drug Details GH-001 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GH-001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GH-001 Drug Details GH-001 is under development for the treatment of treatment-resistant depression, major...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CYB-004
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CYB-004 Drug Details CYB-004 is under development for the treatment of social anxiety disorder...